MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1067/mpd.2002.122498

Медицинская библиотека · The Journal of pediatrics · 2002

Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.

Scothorn Douglas J, Price Cynthia, Schwartz Daniel, Terrill Cindy, Buchanan George R, Shurney Wanda, Sarniak Ingrid, Fallon Robert, Chu Jen-Yih, Pegelow Charles H, Wang Winfred, Casella James F, Resar Linda S, Berman Brian, Adamkiewicz Thomas, Hsu Lewis L, Ohene-Frempong Kwaku, Smith-Whitley Kim, Mahoney Donald, Scott J Paul, Woods Gerald M, Watanabe Masayo, Debaun Michael R

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПоддержка службы здравоохранения СШАПеревод пока не подготовлен

Аннотация

OBJECTIVE

To test the hypothesis that children with sickle cell disease (SCD) who have an initial stroke temporally unrelated to another medical event are at higher risk for recurrent stroke than are children who had strokes temporally related to medical events.

METHODS

A retrospective cohort study of children with SCD and stroke who received regularly scheduled blood transfusions for a minimum of 5 years was conducted. Medical records were examined for the documentation of antecedent or concurrent medical events (hypertension, acute chest syndrome, aplastic crisis, fever associated with infection, exchange transfusion) associated with physician contact within 14 days before the initial stroke.

RESULTS

A total of 137 pediatric patients from 14 centers were studied. Mean age at first stroke was 6.3 years (1.4 to 14.0 years) with mean follow-up of 10.1 years (5 to 24 years). Thirty-one (22%) patients had a second stroke (2.2 per 100 patient years); 26 patients had an identified medical or concurrent event associated with their initial stroke. None of these patients had recurrent stroke 2 or more years after the initial event. The remaining 111 patients had an ongoing risk of recurrent stroke (1.9 per 100 patient-years) despite long-term transfusions (P =.038).

CONCLUSIONS

The absence of an antecedent or concurrent medical event associated with an initial stroke is a major risk factor for subsequent stroke while receiving regular transfusions.

Для цитирования: Scothorn Douglas J, Price Cynthia, Schwartz Daniel, Terrill Cindy, Buchanan George R, Shurney Wanda, Sarniak Ingrid, Fallon Robert, Chu Jen-Yih, Pegelow Charles H, Wang Winfred, Casella James F, Resar Linda S, Berman Brian, Adamkiewicz Thomas, Hsu Lewis L, Ohene-Frempong Kwaku, Smith-Whitley Kim, Mahoney Donald, Scott J Paul, Woods Gerald M, Watanabe Masayo, Debaun Michael R. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke.. The Journal of pediatrics. 2002. DOI: 10.1067/mpd.2002.122498.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.